Membrane and transmembrane signaling in Herpesvirus saimiri-transformed human CD4+ and CD8+ T lymphocytes is ATM-independent

International Immunology

Volumn 12, Issue 6, 2000, Pages 927-935

  Rivero Carmena, Miguel ^a   Porras, Oscar ^b   Pelaez, Blondineth ^a   Pacheco Castro, Alberto ^a   Gatti, Richard A ^c   Regueiro, José R ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL NACIONAL DE NIÑOS   (Costa Rica)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ataxia telangiectasia; ATM protein; Herpesvirus saimiri transformed human T cells; T cell signaling

Indexed keywords

CALCIUM IONOPHORE; CD3 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; GLYCOPROTEIN GP 39; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MEMBRANE RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE;

ARTICLE; ATAXIA TELANGIECTASIA; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DNA SYNTHESIS; HERPES VIRUS SAIMIRI; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; LUNG INFECTION; LYMPHOCYTE TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0034047129     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.6.927     Document Type: Article

References (46)

1. Gatti, R. A. 1998 Ataxia-Telangiectasia, In Vogelstein, B. and Kinzler, K. W., eds, The Genetic Basis of Human Cancer, p. 275, McGraw-Hili, New York.
2. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Miki, T., Weissman, S M., Lovett, M., Collins, F. S. and Shiloh Y. 1995. A single Ataxia-Telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749
3. Keith, C T. and Schreiber S. L. 1995. PI3K-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270:50
4. Zakian, V. A. 1995. ATM-related genes: what do they tell us about functions of the human gene? Cell 82:685.
5. Lim, D. S., Kirsch, D. G., Canman, C. E., Ahn, J. H., Ziv, Y., Newman, L. S., Darnell, R.B., Shiloh, Y. and Kastan, M. B. 1998. ATM binds to beta-adaptin in cytoplasmic vesicles. Proc. Natl Acad. Sci. USA 95:10146.
6. Barlow, C., Hirotsune, S. Paylor, R., Liyanage, M., Eckhaus, M., Collins, F. Shiloh, Y., Crawley, J. N., Ried, T., Tagte, D. and Wynshaw-Boris, A. 1996. Atm-deficient mice: a paradigm of ataxia-telangiectasia. Cell 86:159.
7. Kondo, N., Inoue, R., Nishimura, S., Kasahara, K., Kameyama, T., Miwa, Y., R. Lorenzo P.R. and Orii, T. 1993. Defective calcium-dependent signal transduction in T lymphocytes of ataxia-telangiectasia. Scand. J. Immunol. 38:45.
8. O'Connor, R. D. and Scott-Linthicum, D. 1980. Mitogen receptor redistribution defects and concomitant absence of blastogenesis in ataxia-telangiectasia T lymphocytes. Clin. Immun. Immunopathol. 15.66.
9. Khanna, K. K., Yan, J., Watters, D., Hobson, K., Beamish, H., Spring, K., Shiloh, Y., Gatti, R. A. and Lavin, M. F. 1997. Defective signaling through the B cell antigen receptor in Epstein-Barr virus-transformed Ataxia-Telangiectasia cells. J. Biol. Chem. 272:9489.
10. Lavin, M.F. and Shiloh, Y. 1997. The genetic defect in Ataxia-Telangiectasia. Annu. Rev. Immunol. 15:177.
11. Biesinger, B., Müller-Fleckenstein, I. and Simmer, B. 1992. Stable growth transformation of human T lymphocytes by Herpesvirus saimiri. Proc. Natl Acad. Sci. USA 89:3116.
12. Mittrücker, H. W., Müller-Fleckenstein, I., Reckenstein, B. and Fleischer, B. 1992. CD2-mediated autocrine growth of Herpesvirus saimiri-transformed human T lymphocytes. J. Exp. Med. 176:909.
13. Mittrücker, H. W., Müller-Fleckenstein, I., Fleckenstein, B. and Fleischer, B. 1993. Herpesvirus saimiri-transformed human T lymphocytes: normal functional phenotype and preserved T cell receptor signalling. Int. Immunol. 5:985.
14. h2 human T cell clones. J. Immunol. 151:5022.
15. Kraft, M. S., Henning, G., Fickenscher, H., Lengenfelder, D., Tschopp, J., Fleckenstein, B. and Meinl, E. 1998. Herpesvirus saimiri transforms human T-cell clones to stable growth without inducing resistance to apoptosis. J. Virol. 72:3138.
16. Alvarez-Zapata, D., de Miguel-Olalla, S., Fontán, G., Ferreira, A., García-Rodriguez, M. C., Madero, L., van den Elsen, P. and Regueiro, J. R. 1997. Phenotypical and functional characterization of Herpesvirus saimiri-immortalized human major histocompatibilily complex class II-deficient T lymphocytes. Tissue Antigens. 51:250.
17. + T lymphocytes. J. Immunol. 161:3152.
18. Cabanillas, J. A., García, M. C., Cambronero, R., Fontán, G., Pacheco, A., Ferreira, A. and Regueiro, J. R. 1998. Herpesvirus saimiri-immortalized T cells from patients with Common variable immunodeficiency. Inmunología 17:93.
19. Bröker, B. M., Kraft, M. S., Klauenberg, U., Le Deist, F., de Villartay, J. P., Fleckenstein, B., Fleischer, B. and Meinl, E. 1997. Activation induces apoptosis in Herpesvirus saimiri-transformed T cells independent of CD95 (Fas, APO-1 ). Eur. J. Immunol. 27:2774.
20. Stephan, V., Wahn, V., Le Deist, F., Dirksen, U., Bröker, B., Müller-Fleckenstein, I., Horneff, G., Schroten, H., Fischer, A. and de Saint Basile, G. 1996. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells. N. Engl. J. Med. 335:1563.
21. Gallego, M. D., Santamaria, M., Peña, J. and Molina, I. J. 1997. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 90:3089.
22. Uhrhammer, N., Lange, E., Porras, O., Naeim, A., Chen, X., Sheikhavandi, S., Chiplunkar, S., Yang, L., Dandekar, S., Liang, T., Patel, N., Teraoka, S., Udar, N., Calvo, N., Concannon, P., Lange, K. and Gatti, R. A. 1995. Sublocalization of an ataxia-telangiectasia gene distal to D11S384 by ancestral haplotyping in Costa Rican families. Am. J. Hum. Genet. 57:103.
23. Telatar, M., Castellvi-Bel, S., Tai, L., Wang, Z., Sheikhavandi, S., Rivero-Carmena, M., Regueiro, J. R., Porras, O. and Gatti, R. A. 1998. A model for ATM heterozygote identification in a large population: four founder effect ATM mutations identify most of Costa Rican patients with ataxia-telangiectasia. Mol. Genet. Metab. 64:36.
24. Assenmacher, M., Schmitz, J. and Radbruch, A. 1994. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cell. Eur. J. Immunol. 24:1097.
25. Gallart, T., de la Fuente, M. A., Barceló, J., Alberola-Ila, J. and Lozano, F. 1997. Desialylation of T lymphocytes overcomes the monocyte dependency of pokeweed mitogen-induced T-cell activation. Immunology 90:57.
26. Gorski, A., Grieb, P., Korczak-Kowalska, G. Wierzbicki, P., Stepien-Sopniewska, B. and Mrowiec, T. 1993. Cladribine (2-chloro-deoxyadenosine, CDA): an inhibitor of human B and T cell activation in vitro. Immunopharmacology 26:197.
27. Fickenscher, H., Biesinger, B., Knappe, A., Wittmann, S. and Fleckestein, B. 1996. Regulation of the Herpesvirus saimiri oncogene StpC, similar to that of T cell activation genes, in growth-transformed human T lymphocytes. J. Virol. 70:6012.
28. lck in transformed cells. J. Biol. Chem. 270:4729.
29. Regueiro, J. R., Rodríguez-Gallego, C. and Arnaiz-Villena, A. 1994. Other primary T cell defects. In Regueiro, J. R., Rodríguez-Gallego, C. and Arnaiz-Villena, A., eds, Human T Lymphocyte Activation Deficiencies, p. 35. Landes, Austin, TX.
30. McFarlin, D. E., Strober, W. and Waldmann, T. A. 1972. Ataxia-telangiectasia. Medicine 51:281.
31. Aguilar, M. J., Kamoshita, S., Landing, B. H., Boder, E. and Sedgwick, R. P. 1968. Pathological observations in ataxia-telangiectasia. A report of five cases. J. Neuropathol. Exp. Neurol. 27:659.
32. Peterson, R. D., Kelly, W. D. and Good, R. A. 1964. Ataxia-telangiectasia: its association with a defective thymus, immunological-deficiency disease, and malignancy. Lancet i:1189.
33. Gatti, R. A., Bick, M. B., Tam, C. F., Medici, M. A., Oxelius, V. A., Holland, M., Goldstein, A. L. and Boder, E. 1982 Ataxia-telangiectasia: a multiparameter analysis of eight families. Clin. Immunol. Immunopathol. 23:501.
34. + lymphocytes in patients with ataxia-telangiectasia. J. Clin. Immunol. 12:84.
35. Mackall, C. L., Granger, M.A., Sheard, R., Cepeda, R. and Gress, R. E. 1993. T-cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived versus thymic-independent progeny. Blood 82:2585.
36. Kuljis, R. O., Xu, Y., Aguila, M. C. and Baltimore, D. 1997. Degeneration of neurons, synapses, and neutrophil and glial activation in a murine atm knockout model of ataxia-telangiectasia. Proc. Natl Acad. Sci. USA 94:12688.
37. Lahat, N., Zelnik, N., Froom, P., Kinarty, A. and Etzioni, A. 1988. Impaired autologous mixed lymphocyte reaction (AMLR) in patients with ataxia-telangiectasia and their family members. Clin. Exp. Immunol. 74:32.
38. Paganelli, R., Capobianchi, M. R., Matricardi, P. M., Cioe, L., Seminara, R., Dianzani, F. and Aiuti, F. 1984. Defective interferon-gamma production in ataxia-telangiectasia. Clin. Immunol. lmmunopathol. 32:387.
39. Waldmann, T. A. 1982. Immunological abnormalities in ataxia-telangiectasia. In Bridges, B. A. and Harnden, D. G., eds, Ataxia-telangiectasia: A Cellular and Molecular Link between Cancer, Neuropathology and Immune Deficiency, p. 37. New York, Wiley.
40. Levis, W. R., Dattner, A. M. and Shaw, J. S. 1978. Selective defects in T cell functions in Ataxia-Telangiectasia. Clin. Exp. Immunol. 37:44.
41. Watters, D., Khanna, K. K., Beamish, H., Birrel, G., Spring, K., Kedar, P., Gatei, M., Stenzel, D., Hobson, K., Kozlov, S., Zhang, N., Farrell, A., Ramsay, J., Gatti, R. and Lavin, F. 1997. Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene 14:1911.
42. Hartley, D. A., Hurley, T. R., Hardwick, J. S., Lund, T. C., Medveczky, P. G. and Sefton, B. M. 1999. Activation of the lck tyrosine-protein kinase by the binding of the Tip protein of Herpesvirus saimiri in the absence of regulatory tyrosine phosphorylation. J. Biol. Chem. 274:20056.
43. Yachnin, S. 1976. Demonstration of the inhibitory effect of human alpha-fetoprotein on in vitro transformation of human lymphocytes. Proc. Natl Acad. Sci. USA 73:2857.
44. -/- mice by a functional TCRαβ transgene. J. Immunol. 164:345
45. Fruehling, S. and Longnecker, R. 1997. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology. 235:241.
46. Xu, Y., Ashley, T., Brainerd, E. E. Bronson, R. T., Meyn, M. S. and Baltimore, D. 1996. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:2411.